Though the celebrated appetite suppressant known as Hoodia Gordonii isn’t completely understood as of yet, what is recognized about this diet drug is that it contains the P57 molecule and that is key to its efficacy as a weight loss supplement. This molecule was first patented by Phytopharm, a British pharmaceutical company. Over the last few years, research has shown time and time again that within Hoodia Gordonii diet pills, the P57 molecule is a significant contributor to its efficacy in weight loss within its users.
The P57 molecule works within the central nervous system as a steroidal glycoside, most significantly within the part of the brain known as the hypothalamus. It functions by telling the brain that you are no longer hungry by releasing a sensation of being full much sooner than you would feel if you were not on the medication. This allows the body to feel satisfied from hunger much more quickly and for a longer period of time so that more reasonably sized portions are eaten and the temptations to snack or overeat are diminished.
The P57 molecule has been linked to the cactus-like plant called hoodia, which is found in nature within the South African Kalahari Desert. It was Phytopharm that first discovered this plant, and from this discovery, they spent a reported $20 million or more in order to isolate the P57 molecule component. It was their initial desire to not only find out its true capabilities, but also to identify every way in which it can both benefit or harm its users.
It was at this time that Phytopharm gave the molecule the name P57 and gave it a patent to ensure their exclusivity. Though they continue to perform research on the plant as a whole as well as the molecule, the findings so far have been astounding. For one thing, Phytopharm’s studies have discovered that when people consume a supplement containing P57, they will, on average, eat 1,000 fewer calories every day.
In order to further perform their investigations, Phytopharm partnered with the pharmaceutical giant, Pfizer, allowing them to work toward a highly effective weight loss drug that could achieve FDA approval and be released into the American drug market. Surprisingly, it was Pfizer’s determination that a pill could not be created with the active form of P57 and they therefore backed out.
Since that time, Phytopharm has continued to work on a way to integrate P57 into an effective diet pill. This has not yet been accomplished, but they remain hopeful. Until then the Hoodia supplements, though highly effective, do not yet contain that one ingredient that would make the most significant, overwhelmingly helpful difference in weight loss pill history.